Success Metrics

Clinical Success Rate
94.1%

Based on 32 completed trials

Completion Rate
94%(32/34)
Active Trials
4(10%)
Results Posted
22%(7 trials)
Terminated
2(5%)

Phase Distribution

Ph phase_4
18
44%
Ph phase_1
11
27%
Ph phase_2
6
15%
Ph not_applicable
2
5%
Ph phase_3
4
10%

Phase Distribution

11

Early Stage

6

Mid Stage

22

Late Stage

Phase Distribution41 total trials
Phase 1Safety & dosage
11(26.8%)
Phase 2Efficacy & side effects
6(14.6%)
Phase 3Large-scale testing
4(9.8%)
Phase 4Post-market surveillance
18(43.9%)
N/ANon-phased studies
2(4.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.1%

32 of 34 finished

Non-Completion Rate

5.9%

2 ended early

Currently Active

4

trials recruiting

Total Trials

41

all time

Status Distribution
Active(5)
Completed(32)
Terminated(2)
Other(2)

Detailed Status

Completed32
Recruiting3
Terminated2
unknown2
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
41
Active
4
Success Rate
94.1%
Most Advanced
Phase 4

Trials by Phase

Phase 111 (26.8%)
Phase 26 (14.6%)
Phase 34 (9.8%)
Phase 418 (43.9%)
N/A2 (4.9%)

Trials by Status

not_yet_recruiting12%
terminated25%
unknown25%
completed3278%
recruiting37%
active_not_recruiting12%

Recent Activity

Clinical Trials (41)

Showing 20 of 41 trialsScroll for more
NCT07526558Phase 2

Mast Cell Treatment in Post-tick Bite Illness (PTBI)

Not Yet Recruiting
NCT07118215Phase 1

A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and Digoxin

Recruiting
NCT06785298Phase 2

Fexofenadine as Adjuvant Therapy in Parkinson Disease

Recruiting
NCT06019728Phase 4

A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme

Completed
NCT05692154Phase 3

A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis

Completed
NCT05264025Phase 1

Fexofenadine in Patients With Active Rheumatoid Arthritis

Recruiting
NCT04688788Phase 3

Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis

Active Not Recruiting
NCT06466421Phase 4

Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis

Completed
NCT06205381Phase 1

Assessment of the Safety, Tolerability and Pharmacokinetics of AV078 in Healthy Volunteers

Completed
NCT00783211Phase 4

Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR)(Study P04053)(COMPLETED)

Completed
NCT00783146Phase 4

Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054)

Completed
NCT00783133Phase 4

Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03177)

Completed
NCT03994731Phase 4

Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout

Completed
NCT03933007Phase 4

Relation Between Blood Concentration of Colchicine and Response to Colchicine Treatment in Gout Flare

Terminated
NCT05932277Phase 1

A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy Participants

Completed
NCT00794248Phase 4

Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03179)

Completed
NCT00794768Phase 4

Preference for Clarinex Tablets vs Allegra Tablets in Patients With Seasonal Allergies (P03178)

Completed
NCT03108274Phase 1

A Drug Interaction Study Between Danicopan and Midazolam, Fexofenadine, and Mycophenolate Mofetil in Healthy Participants

Completed
NCT03425097Phase 2

Fexofenadine Use in Gastroesophageal Reflux Symptoms

Terminated
NCT03078777Phase 4

The Effect Dialysis on the Pharmacokinetics of Fexofenadine

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
41